Article
Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
2022-03-20
Abstract excerpt
<h4>Summary</h4> Despite the remarkable efficacy of COVID-19 vaccines, waning immunity, and the emergence of SARS-CoV-2 variants such as Omicron represents a major global health challenge. Here we present data from a study in non-human primates demonstrating durable protection against the Omicron BA.1 variant induced by a subunit SARS-CoV-2 vaccine, consisting of RBD (receptor binding domain) on the I53-50 nanopa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2ac88fff-b623-50bf-bf6f-249ad4dbe7e4
- DOI
- 10.1101/2022.03.18.484950
